ÂÜÀòÂÒÂ×

Nayaki Muthusamy, PhD, is a seasoned professional in biomarker research and preclinical development. Currently serving as Program Lead at HanAll Biopharma since July 2024, Muthusamy focuses on proposing strategies for identifying biomarkers and assessing CRO capabilities related to inflammatory and neurodegenerative diseases. Previously, as Senior Scientist at Annexon Biosciences, Muthusamy designed and executed studies supporting clinical programs and developed biomarker strategies for autoimmune disorders. Muthusamy's experience includes leading preclinical projects at Applied Molecular Transport, conducting cancer biology research at UCSF, and studying protein trafficking during graduate studies at Vanderbilt University. Educational credentials include a PhD in Cellular and Molecular Biology from Vanderbilt University and a DVM from Madras Veterinary College.